Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators

Journal

N Engl J Med

Volume

364

Issue

Pages

907-17

Publication year

2011

Suggested citation

Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011; 364(10): 907-17.

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Nav